CECIL B. PICKETT, Ph.D.

Cecil B. Pickett, Ph.D., is president, Schering-Plough Research Institute, the pharmaceutical research arm of Schering-Plough Corporation, a research-based company engaged in the discovery, development, manufacturing and marketing of pharmaceutical products worldwide.

Dr. Pickett was appointed to his present position in March 2002. He joined Schering-Plough Research Institute in 1993, and most recently was executive vice president, discovery research, responsible for the planning, management and oversight of Schering-Plough's new drug discovery programs across all therapeutic areas, and for coordinating those programs with other research and commercial components in the Company. Dr. Pickett came to Schering-Plough Research Institute ftom Merck Research Laboratories, Montreal, Canada, and West Point, Pa., where he served as senior vice president, basic research. Dr. Pickett received his B.S. degree in biology from California State University, Hayward, Calif., and his Ph.D. degree in cell biology from the University of California, Los Angeles (UCLA). Dr. Pickett serves as a member of the U.S. Food and Drug Administration (FDA) Science Board, the Advisory Committee to the Director of the National Institutes of Health and The National Cancer Policy Board of the Institute of Medicine. He was elected to the Institute of Medicine of the National Academy of Sciences in 1993.